TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Atlas Arteria ( (AU:ALX) ).
Atlas Arteria has released its results presentation for the half year ended 30 June 2025, highlighting its ongoing operations across its international toll road portfolio. The announcement underscores the company’s commitment to maintaining its market position through strategic management and sustainable practices, which is likely to impact stakeholders positively by reinforcing its operational stability and growth potential.
The most recent analyst rating on (AU:ALX) stock is a Buy with a A$5.70 price target. To see the full list of analyst forecasts on Atlas Arteria stock, see the AU:ALX Stock Forecast page.
More about Atlas Arteria
Atlas Arteria (ASX:ALX) is a company that partners to deliver world-class road experiences, focusing on creating long-term value through disciplined management and sustainable business practices. The company operates toll road businesses in France, Germany, and the United States, including significant interests in the APRR, AREA, A79, and ADELAC motorway networks in France, the Chicago Skyway in the US, and the Warnow Tunnel in Germany.
Average Trading Volume: 2,012,556
Technical Sentiment Signal: Buy
Current Market Cap: A$7.82B
For a thorough assessment of ALX stock, go to TipRanks’ Stock Analysis page.